Glenmark Pharmaceuticals granted FDA acceptance to proceed with clinical trial of GRC 54276 for advanced solid tumors and lymphomas
Glenmark Pharmaceuticals, a global innovation-driven pharmaceuticals company, has announced that the US Food and Drug Administration (FDA) has accepted its...